Aprea Therapeutics
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $561 | $380 |
Gross Profit | 556 | 374 | ||
EBITDA | -4,091 | -3,846 | -3,143 | |
EBIT | -4,097 | -3,852 | -3,149 | |
Net Income | -2,894 | -3,783 | -3,470 | -2,810 |
Net Change In Cash | 0 | 0 | 561 | 380 |
Free Cash Flow | -3,510 | -2,468 | -3,546 | -3,943 |
Cash | 22,849 | 26,249 | 28,694 | 32,369 |
Basic Shares | 5,434 | 5,939 | 5,937 | 4,198 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $583 | $0 | $0 |
Gross Profit | 576 | -186 | -271 | |
EBITDA | -14,319 | -14,279 | -112,475 | -36,855 |
EBIT | -14,286 | -112,662 | -37,127 | |
Net Income | -12,958 | -14,286 | -224,875 | -36,536 |
Net Change In Cash | 0 | 583 | 0 | 0 |
Free Cash Flow | -13,572 | -12,270 | -25,011 | -37,686 |
Cash | 22,849 | 21,606 | 28,786 | 53,076 |
Basic Shares | 5,509 | 3,617 | 82 | 1,064 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.49 |
2024-09-30 | -$0.64 |
2024-06-30 | -$0.58 |
2024-03-31 | -$0.67 |
